Published in J Clin Pathol on March 01, 2006
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Clinical features and management of autoimmune hepatitis. World J Gastroenterol (2008) 1.05
Autoantibody-negative autoimmune hepatitis. Dig Dis Sci (2011) 1.03
Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci (2010) 1.01
Autoimmune hepatitis. Semin Immunopathol (2009) 0.88
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol (2006) 0.82
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol (2015) 0.81
Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis (2012) 0.79
Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One (2014) 0.78
IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage. Ital J Pediatr (2010) 0.78
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights (2013) 0.78
The importance of autoantibody detection in autoimmune hepatitis. Front Immunol (2015) 0.78
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver (2016) 0.77
Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol (2007) 0.76
To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol (2017) 0.75
Diagnostic autoantibodies for autoimmune liver diseases. Clin Transl Immunology (2017) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Diagnosis and treatment of autoimmune hepatitis. Hepatology (2002) 3.13
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol (1976) 2.08
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57
Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. Autoimmunity (1991) 1.50
Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol (1979) 1.42
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol (1983) 1.09
Whither smooth muscle antibodies in the third millennium? J Clin Pathol (2001) 1.02
Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol (1999) 1.02
Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett (1995) 1.00
Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol (2005) 0.95
Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity (2002) 0.91
Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture. Hepatology (1996) 0.90
Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection. J Autoimmun (2001) 0.87
Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA. J Clin Lab Anal (2002) 0.85
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 3.28
Over-the-counter medication use among US preschool-age children. JAMA (1994) 3.24
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68
The effect of gaps in health insurance on continuity of a regular source of care among preschool-aged children in the United States. JAMA (1995) 2.55
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
The effects of poverty, race, and family structure on US children's health: data from the NHIS, 1978 through 1980 and 1989 through 1991. Am J Public Health (1996) 2.13
Elucidating the relationships between race, socioeconomic status, and health. Am J Public Health (1994) 1.99
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery (1971) 1.79
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Bacterial endocarditis caused by Oerskovia turbata. Ann Intern Med (1975) 1.61
Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod (2008) 1.57
Surgical management of absent right pulmonary artery with associated pulmonary hypertension. Chest (1983) 1.54
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 1.47
Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online (2007) 1.47
Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance. Scand J Infect Dis (1993) 1.44
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
The widening gap in death rates among income groups in the United States from 1967 to 1986. Int J Health Serv (2000) 1.42
Influence of environmental iodine deficiency on neonatal thyroid screening results. J Endocrinol Invest (1988) 1.41
Bile duct cell apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis (2001) 1.40
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
[Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation]. Acta Gastroenterol Latinoam (2000) 1.39
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet (1991) 1.38
Pulmonary allograft conduit repair of tetralogy of Fallot. An alternative to transannular patch repair. J Thorac Cardiovasc Surg (1989) 1.38
Thyroid function in systemic sclerosis. J Endocrinol Invest (1991) 1.38
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther (2000) 1.38
Evolution of the management of anomalous left coronary artery: a new surgical approach. Ann Thorac Surg (1989) 1.37
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
[Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy?]. Med Trop (Mars) (2003) 1.32
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Prospects, problems, and prerequisites for national health examination surveys in developing countries. Soc Sci Med (1996) 1.29
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Basement membrane production by hepatocytes in chronic liver disease. Hepatology (1985) 1.21
Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate. Br J Exp Pathol (1973) 1.20
Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol (1993) 1.20
IgA antiendomysial antibody test. A step forward in celiac disease screening. Dig Dis Sci (1991) 1.16
Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet (1985) 1.14
Evaluation of serum rosette inhibitory factors in chronic liver disease. Clin Exp Immunol (1983) 1.14
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol (2001) 1.12
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
The socio-ecology of zoonotic infections. Clin Microbiol Infect (2011) 1.11
TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene (2001) 1.11
IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nat Cell Biol (2002) 1.10
Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin Exp Immunol (1974) 1.10
Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology (1998) 1.09
Characterization of a 2D ion chamber array for the verification of radiotherapy treatments. Phys Med Biol (2005) 1.09
Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology (1994) 1.09
A large scale analysis of resistance gene homologues in Arachis. Mol Genet Genomics (2003) 1.07
Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol (1989) 1.06
Review article: autoimmune hepatitis -- current management and challenges. Aliment Pharmacol Ther (2013) 1.05
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol (2003) 1.04